Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

N-acetylglutamate Synthase (NAGS) Deficiency clinical trials

1 of 1 indexed N-acetylglutamate Synthase (NAGS) Deficiency trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

N-acetylglutamate Synthase (NAGS) Deficiency: 1 US clinical trial tracked, 1 recruiting.

N-acetylglutamate Synthase (NAGS) Deficiency is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Nicholas Ah Mew, running 1 of these trials.

Enrollment posture brief

Registry condition n-acetylglutamate-synthase-nags-deficiency

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

N-acetylglutamate Syntha (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near N-acetylglutamate Synthase (NAGS) Deficiency

N-acetylglutamate Synthase (NAGS) Deficiency lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for N-acetylglutamate Synthase (NAGS) Deficiency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. N-acetylglutamate Synthase (NAGS) Deficiency is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Nicholas Ah Mew 1 trials

US sites by state

Facility locations filed on N-acetylglutamate Synthase (NAGS) Deficiency trials. A trial with sites in several states counts in each.

New York 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this N-acetylglutamate Synthase (NAGS) Deficiency page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 N-acetylglutamate Synthase (NAGS) Deficiency trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Nicholas Ah Mew sponsors the most N-acetylglutamate Synthase (NAGS) Deficiency trials on record, review their full trial history before evaluating a specific study. See Nicholas Ah Mew's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This N-acetylglutamate Synthase (NAGS) Deficiency condition card totals 1 registered trials; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.